More bronchiectasis patients benefit from macrolides

Current European guidelines should not be seen as ‘strict rules’, study suggests

Long-term use of macrolides for bronchiectasis can reduce and delay exacerbations and improve quality of life even in patients currently excluded in guidelines, a meta-analysis shows.